Showing results (51-60 of 55) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Bioorganic & Medicinal Chemistry Letters|October 15, 2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active siteWei Wang, Pratik Devasthale, Aiying Wang, et al.Journal of AOAC International|May 29, 2004
Harmonization of methods for analysis of cholesterol oxides in foods--the first portion of a long road toward standardization: interlaboratory studyLars-Ake Appelqvist, Paul Addis, Ingemar Björkhem, et al.Journal of Medicinal Chemistry|August 23, 2013
Optimization of activity, selectivity, and liability profiles in 5-oxopyrrolopyridine DPP4 inhibitors leading to clinical candidate (Sa)-2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)Pratik Devasthale, Ying Wang, Wei Wang, et al.Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi-Qiang Sun, Eric Mull, Barbara Zheng, et al.Pageof 6